Key result
Discharge medicines review linked to ~40% lower hospital readmission risk versus no review.
Why the study?
The association of the discharge medicines review community pharmacy service with hospital readmissions was evaluated through linking national NHS data sets in Wales.
Does a discharge medicines review (DMR) community pharmacy service reduce hospital readmissions in discharged inpatients?
Cohort (n=1,923)
Yes
Does a discharge medicines review (DMR) community pharmacy service reduce hospital readmissions in discharged inpatients?
A discharge medicines review by community pharmacists is associated with a significantly lower risk of hospital readmission within 40 days.
Answers are grounded in this paper and cite their sources.
DMR receipt was associated with lower 40-day readmission risk; leaves open whether randomized trials will confirm benefit or guide adoption.
OBJECTIVE: To evaluate the association of the discharge medicines review (DMR) community pharmacy service with hospital readmissions through linking National Health Service data sets. DESIGN: Retrospective cohort study. SETTING: All hospitals and 703 community pharmacies across Wales. PARTICIPANTS: Inpatients meeting the referral criteria for a community pharmacy DMR. INTERVENTIONS: Information related to the patient's medication and hospital stay is provided to the community pharmacists on discharge from hospital, who undertake a two-part service involving medicines reconciliation and a medicine use review. To investigate the association of this DMR service with hospital readmission, a data linking process was undertaken across six national databases. PRIMARY OUTCOME: Rate of hospital readmission within 90 days for patients with and without a DMR part 1 started. SECONDARY OUTCOME: Strength of association of age decile, sex, deprivation decile, diagnostic grouping and DMR type (started or not started) with reduction in readmission within 90 days. RESULTS: testing and classification methods. Cox regression survival analysis demonstrated that those receiving the intervention had a lower hospital readmission rate at 40 days (p<0.000, HR: 0.59739, CI 0.5043 to 0.7076). CONCLUSIONS: DMR after a hospital discharge is associated with a reduction in risk of hospital readmission within 40 days. Linking data across disparate national data records is feasible but requires a complex processual architecture. There is a significant value for integrated informatics to improve continuity and coherency of care, and also to facilitate service optimisation, evaluation and evidenced-based practice.
No takes yet. Share an insight, caveat, or question.
Mantzourani et al. (2020) conducted a cohort in Hospital discharge (n=1,923). Discharge medicines review (DMR) vs. No discharge medicines review was evaluated on Hospital readmission rate at 40 days (HR 0.59739, 95% CI 0.5043-0.7076, p=<0.001). A discharge medicines review after hospital discharge was associated with a lower risk of hospital readmission within 40 days compared to no review.
Synapse has enriched 10 related papers. Consider them for comparative context: